LY3039478

LY3039478 Struktur
1421438-81-4
CAS-Nr.
1421438-81-4
Englisch Name:
LY3039478
Synonyma:
LY3039478;Crenigacestat;LY3039478(Crenigacestat);CRENIGACESTAT (LY3039478);LY3039478; LY 3039478; LY-3039478; CRENIGACESTAT;4-trifluoro-N-((S)-1-(((S)-5-(2-hydroxyethyl)-6-oxo-6;Inhibitor,γ-secretase,Crenigacestat,liver,LY 3039478,Notch,Gamma secretase,inhibit,LY-3039478,CCRCC;4,4,4-Trifluoro-N-((S)-1-(((S)-5-(2-hydroxyethyl)-6-oxo-6,7-dihydro-5H-benzo[d]pyrido[2,3-b]azepin-7-yl)amino)-1-oxopropan-2-yl)butanamide;N-[(1S)-2-[[(7S)-6,7-Dihydro-5-(2-hydroxyethyl)-6-oxo-5H-pyrido[3,2-a][3]benzazepin-7-yl]amino]-1-methyl-2-oxoethyl]-4,4,4-trifluorobutanamide;Butanamide, N-[(1S)-2-[[(7S)-6,7-dihydro-5-(2-hydroxyethyl)-6-oxo-5H-pyrido[3,2-a][3]benzazepin-7-yl]amino]-1-methyl-2-oxoethyl]-4,4,4-trifluoro-
CBNumber:
CB52677403
Summenformel:
C22H23F3N4O4
Molgewicht:
464.44
MOL-Datei:
1421438-81-4.mol

LY3039478 Eigenschaften

Siedepunkt:
818.7±65.0 °C(Predicted)
Dichte
1.41±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
≥23.2 mg/mL in DMSO; insoluble in H2O; ≥89.4 mg/mL in EtOH with ultrasonic
Aggregatzustand
solid
pka
12.75±0.20(Predicted)
Farbe
White to off-white

Sicherheit

LY3039478 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

LY 3039478 is used in the preparation of medicaments for combination antitumor therapy with Notch and PD-1 or PD-Li inhibitors.

LY3039478 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


LY3039478 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 70)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32760 60
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226
sales@hzclap.com CHINA 6313 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471
sales@sarms4muscle.com China 10522 58
InvivoChem
+1-708-310-1919 +1-13798911105
sales@invivochem.cn United States 6393 58
TargetMol Chemicals Inc.
+1-781-999-5354
support@targetmol.com United States 19973 58
Aceschem Inc.
+1-817863-6948 +1-(817)863-6948
sales@aceschem.com United States 19639 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525
masar@topule.com China 8474 58
Henan Fengda Chemical Co., Ltd
+86-371-86557731 +86-13613820652
info@fdachem.com China 20314 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 57511 58
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131980 58

  • LY3039478
  • 4,4,4-Trifluoro-N-((S)-1-(((S)-5-(2-hydroxyethyl)-6-oxo-6,7-dihydro-5H-benzo[d]pyrido[2,3-b]azepin-7-yl)amino)-1-oxopropan-2-yl)butanamide
  • N-[(1S)-2-[[(7S)-6,7-Dihydro-5-(2-hydroxyethyl)-6-oxo-5H-pyrido[3,2-a][3]benzazepin-7-yl]amino]-1-methyl-2-oxoethyl]-4,4,4-trifluorobutanamide
  • LY3039478(Crenigacestat)
  • CRENIGACESTAT (LY3039478)
  • Butanamide, N-[(1S)-2-[[(7S)-6,7-dihydro-5-(2-hydroxyethyl)-6-oxo-5H-pyrido[3,2-a][3]benzazepin-7-yl]amino]-1-methyl-2-oxoethyl]-4,4,4-trifluoro-
  • Crenigacestat
  • LY3039478; LY 3039478; LY-3039478; CRENIGACESTAT
  • 4-trifluoro-N-((S)-1-(((S)-5-(2-hydroxyethyl)-6-oxo-6
  • Inhibitor,γ-secretase,Crenigacestat,liver,LY 3039478,Notch,Gamma secretase,inhibit,LY-3039478,CCRCC
  • 1421438-81-4
  • C22H23F3N4O4
  • APIS
Copyright 2019 © ChemicalBook. All rights reserved